Results 181 to 190 of about 1,322,023 (308)

Analysis of queries in an HIV drug–drug interaction checker to explore changes in prescribing patterns: A 5‐year analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Careful consideration of drug–drug interactions (DDIs) is critical as people with HIV age. We analysed queries submitted to the University of Liverpool HIV Drug Interactions Database to assess changes in prescribing patterns over 5 years. Methods Queries submitted between January 2020 and December 2024 were extracted and categorized by year ...
Cecile Gras   +6 more
wiley   +1 more source

Lenacapavir initiation with concomitant primidone: A case report with therapeutic drug monitoring

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Lenacapavir (LEN), a first‐in‐class capsid inhibitor, has unique pharmacokinetics that enable twice‐yearly dosing. LEN is not extensively metabolized, although it is a substrate of CYP3A4, which introduces drug–drug interactions concerns. As adoption and implementation of LEN for treatment and prevention increase, additional guidance on concomitant ...
Aaron S. Devanathan   +6 more
wiley   +1 more source

HIV and nanobacteria [PDF]

open access: yesHIV Medicine, 2004
A-M, Pretorius   +3 more
openaire   +2 more sources

Incidence and predictors of mother-to-child transmission of HIV among HIV-exposed infants in public General hospitals of Tigray, Ethiopia, 2020: Retrospective cohort study. [PDF]

open access: yesPLoS One
Gerezgiher GG   +8 more
europepmc   +1 more source

A British Pharmacological Society Position Statement on Medications in Pregnancy and Lactation

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Agnesa Mustafa   +14 more
wiley   +1 more source

Tenofovir diphosphate intracellular concentration following tenofovir alafenamide administration in bictegravir‐containing vs. dolutegravir‐containing antiretroviral regimens

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
This study investigates intracellular (IC) exposure of tenofovir alafenamide (TAF) and its clinical determinants in experienced people living with HIV. We conducted a monocentric retrospective analysis of 86 adults treated with either bictegravir (BIC)‐ or dolutegravir (DTG)‐containing regimen. Plasma and IC trough concentrations (Ctrough) of tenofovir
Micol Ferrara   +10 more
wiley   +1 more source

Prevalence of Hypertension, Diabetes, Obesity, and High Cholesterol Among Older People Living With HIV: A Systematic Review and Meta-Analysis

open access: yesAIDS Research and Treatment
Mahkameh Rafiee   +7 more
doaj   +1 more source

Management of HIV-Associated Cancers in Sub-Saharan Africa: A Scoping Review of Treatment Outcomes, Challenges, and Strategies for Enhancing Care. [PDF]

open access: yesInfect Dis Rep
Oisakede EO   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy